Search
Acylcarnitine (6Z)-Pentadec-6-enoylcarnitine
smpdb.ca/view/SMP0124232Metabolic(6Z)-Pentadec-6-enoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, (6Z)-pentadec-6-enoyl-CoA reacts with L-carnitine to form (6Z)-pentadec-6-enoylcarnitine. This reaction is catalyzed by carnitine O-palmitoyltransferase.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreRituximab
go.drugbank.com/drugs/DB00073ApprovedInvestigationalFDA in 1997 as a single agent to treat patients with B-cell Non-Hodgkin's Lymphoma (NHL) [L4811], however, has now been approved for a variety of conditions [FDA label]. … Rituximab is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes.
Categories: CHOP-R chemotherapy regimenProducts: MABTHERA® SOLUCIÓN INYECTABLE 1400 MG/11.7 ML (120MG/ML), MABTHERA 1400 MG/11,7 ML SC ENJEKSIYONLUK ÇÖZELTI, 1 ADETIdarucizumab
go.drugbank.com/drugs/DB09264ApprovedIdarucizumab protein structure can be viewed below, with disulfide bridges at the following points: H22-H95, H149-H205, H225-L-219, L23-L93, L139-L199. … Idarucizumab is a humanized monoclonal antibody fragment (Fab) derived from an immunoglobulin G1 isotype molecule that binds to and inactivates the oral anticoagulant dabigatran, thereby reversing its
Products: PRAXBİND 50 MG/ML ENJEKSİYONLUK/İNFÜZYONLUK ÇÖZELTİ, 2 ADET, PRAXBIND®Voltage-dependent L-type calcium channel subunit beta-4
go.drugbank.com/bio_entities/BE0002356TargetHumansThe beta subunit of voltage-dependent calcium channels contributes to the function of the calcium channel by increasing peak calcium current, shifting the voltage dependencies of activation and inactivation, modulating G protein inhibiti...
Polypeptides: Voltage-dependent L-type calcium channel subunit beta-4Synonyms: Calcium channel voltage-dependent subunit beta 4Putative dehydrogenase/reductase SDR family member 4-like 1
go.drugbank.com/bio_entities/BE0003983TargetHumansPutative oxidoreductase
Polypeptides: Putative dehydrogenase/reductase SDR family member 4-like 1Synonyms: Short chain dehydrogenase/reductase family 25C member 4Zonisamide
go.drugbank.com/drugs/DB00909ApprovedInvestigationalIn 1989, it was approved for commercial use in Japan. The US and Europe approved it in 2000 and 2005, respectively.[A1379,A1383] … Zonisamide is a sulfonamide anticonvulsant used as an adjunctive therapy in adults with partial-onset seizures.
Categories: Compounds used in a research, industrial, or household setting, P-glycoprotein inhibitorsSynonyms: Benzo[d]isoxazol-3-yl-methanesulfonamide, 1,2-Benzisoxazole-3-methanesulfonamideVenlafaxine
go.drugbank.com/drugs/DB00285ApprovedInvestigational[A252065] Venlafaxine has been used as a first-line treatment for MDD, GAD, social anxiety disorder, and panic disorder in Canada for many years. … Venlafaxine is an antidepressant and a serotonin and norepinephrine reuptake inhibitor (SNRI).
Categories: P-glycoprotein inhibitors, P-glycoprotein substratesProducts: VENOXOR®75 MG, VENLAFAXINA SUNEthosuximide
go.drugbank.com/drugs/DB00593ApprovedInvestigationalAn anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
Categories: Cytochrome P-450 Substrates, Heterocyclic Compounds, 1-RingSynonyms: 2-ethyl-2-methylsuccinimide, (±)-2-ethyl-2-methylsuccinimideLarotrectinib
go.drugbank.com/drugs/DB14723ApprovedInvestigationalLarotrectinib is an orally administered inhibitor of tropomyosin receptor kinase (Trk), a receptor tyrosine kinase activated by neurotrophins which is mutated in a variety of cancer cell types and plays … of cell growth in tumors that overexpress Trk.
Categories: P-glycoprotein substrates, Cytochrome P-450 SubstratesProducts: VITRAKVI®CÁPSULAS DE 100MG, VITRAKVI 25 MG SERT KAPSÜL, 56 ADETAcylcarnitine 3-Hydroxy-6-octenoylcarnitine
smpdb.ca/view/SMP0123375Metabolic3-Hydroxy-6-octenoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, 3-hydroxy-6-octenoyl-CoA reacts with L-carnitine to form 3-hydroxy-6-octenoylcarnitine. This reaction is catalyzed by carnitine O-palmitoyltransferase.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 more